TABLE 2.
Disease/Physiology | miRNA | Target Proteins/Signaling Pathway | Effect | Ref |
---|---|---|---|---|
Osteoporosis | miR-214 | YAP1 | Promoting osteogenic differentiation | Zhong et al. (2021) |
IDD | miR-17-5p | SOX4; Wnt/β-catenin (activating) | Promoting ECM degradation and NP cell apoptosis | Zhang et al. (2021) |
Myocardial I/R injury | miR-17-5p | Wnt/β-catenin (inactivating) | Enhancing cardiomyocyte viability and ATP concentration; Inhibiting cardiomyocyte apoptosis | Zhang et al. (2020) |
DOXIC | miR-330-5p | SIRT6, Survivin, SERCA2a | Alleviating cell/mitochondrial oxidative stress and DNA damage | Han et al. (2020) |
DR | -- | MMP-2, MMP-9, TNF-α | Preventing neovascularization and inflammation to delay DR progression | Zhou et al. (2021a) |
DN | miR-33a-5p | SIRT6 | Ameliorating renal inflammation and fibrosis | Liu et al. (2021) |
HSCR | miR-146b-5p | RET; MAPK | Promoting cell proliferation and migration to delay HSCR progression | Xia et al. (2022) |
PDLSC | -- | MAPK | Promoting osteogenic differentiation | Gu et al. (2017) |